93
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study

, , , , , , , , , & show all
Pages 37-43 | Published online: 07 Jan 2021

References

  • The Central People’s Government of the People’s Republic of China. The World Health Organization named the novel coronavirus pneumonia as “COVID-19” [EB/OL]. [2020 212]. http://www.gov.cn/xinwen/2020–02/12/content_5478891.htm.
  • Wu ZY, McGoogan JM. Characteristics of and important lessons from coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.264832091533
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Chen WQ, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1–12. doi:10.21147/j.issn.1000-9604.2018.01.0129545714
  • Barton MB, Jacob S, Shafiq J, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol. 2014;112(1):140–144. doi:10.1016/j.radonc.2014.03.02424833561
  • Yang YQ, Shen CY, Hu CS. Effect of COVID-19 epidemic on delay of diagnosis and treatment path for patients with nasopharyngeal carcinoma. Cancer Manag Res. 2020;12:3859–3864. doi:10.2147/CMAR.S25409332547222
  • Wang XS, Zeng M. Challenges for a cancer center in the novel coronavirus pneumonia epidemic. Technol Cancer Res Treat. 2020;19:1533033820945774. doi:10.1177/153303382094577432783511
  • Mendlovic J, Weiss G, Da’as N, et al. Internal medicine patients admitted without COVID-19 during the outbreak. Int J Clin Pract. 2020;74:undefined: e13630. doi:10.1111/ijcp.13630
  • Zhong PJ, Xu J, Yang D, et al. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther. 2020;5(1):256. doi:10.1038/s41392-020-00373-733139693
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
  • Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
  • Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill. 2020;25(5):2000062. doi:10.2807/1560-7917.ES.2020.25.5.2000062
  • Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-931986261
  • National Health Commission of the People’s Republic of China. 410 Announcement of the National Health Commission of People’s Republic of China (2020 No.1) [EB/OL]. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202001/44a3b8245e8049d2837a4f27529cd386.shtml. Accessed Jan 10, 2020.
  • Liang WH, Guan WJ, Chen RC, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/S1470-2045(20)30096-632066541
  • McMillan MT, Ojerholm E, Verma V, et al. Radiation treatment time and overall survival in locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;98(5):1142–1152. doi:10.1016/j.ijrobp.2017.04.00428721898
  • Wei W, Zheng DD, Lei Y, et al. Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: experience of the hubei cancer hospital in Wuhan, China. Radiother Oncol. 2020;148:203–210. doi:10.1016/j.radonc.2020.03.02932342870
  • Buglione M, Spiazzi L, Guerini AE, et al. Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice. Radiat Oncol. 2020;15(1):191. doi:10.1186/s13014-020-01631-232778174
  • Suárez-Gironzini V, Moreno-Olmedo E, Pérez M, et al. Spanish risk management framework across 17 radiation oncology centers during COVID-19 pandemic. Radiother Oncol. 2020;148:267–269. doi:10.1016/j.radonc.2020.05.04132479777
  • Montesi G, Di Biase S, Chierchini S, et al. Radiotherapy during COVID-19 pandemic. How to create a No fly zone: a northern Italy experience. Radiol Med. 2020;125(6):600–603. doi:10.1007/s11547-020-01217-832415473
  • Meattini I, Franco P, Belgioia L, et al. Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation’s young oncologists. ESMO Open. 2020;5(2):e000779. doi:10.1136/esmoopen-2020-00077932295769
  • Xie C, Wang X, Liu H, et al. Outcomes in radiotherapy-treated patients with cancer during the COVID-19 outbreak in Wuhan, China. JAMA Oncol. 2020;6(9):1457–1459. doi:10.1001/jamaoncol.2020.278332729893